- €433.98m
- €524.11m
- €454.30m
- 64
- 36
- 96
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 326 | 335 | 423 | 375 | 454 |
Cost of Revenue | |||||
Gross Profit | 112 | 111 | 125 | 129 | 151 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 316 | 324 | 407 | 362 | 440 |
Operating Profit | 9.14 | 11.4 | 16 | 12.1 | 13.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.53 | 8.95 | 15.1 | 10.2 | 13.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.71 | 7.57 | 11.9 | 7.52 | 11.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5.49 | 7.27 | 11.6 | 7.22 | 10.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.49 | 7.27 | 11.6 | 7.22 | 10.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.183 | 0.276 | 0.44 | 0.274 | 0.392 |
Dividends per Share |